PharVision Advisers’s Costco COST Stock Holding History

PharVision Advisers’s Portfolio COST Stock Details COST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-533	Closed	-$460K	–	225
2025 Q4	$460K	Buy	533 +137	+35%	+$124K	0.23%	62
2025 Q3	$367K	Buy	396 +93	+31%	+$89.1K	0.21%	114
2025 Q2	$300K	Buy	+303	New	+$301K	0.43%	81

Other funds holding COST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's COST Position: Q1 2026 in Review

PharVision Advisers sold out of Costco (COST) in Q1 2026, closing a stake of 533 shares — an estimated $460K sold.

PharVision Advisers first reported a position in COST in Q2 2025 and held it in 3 quarters. The position peaked at $460K in Q4 2025. 4,238 funds tracked by Wall St. Rank hold COST as of Q1 2026.

PharVision Advisers reported no remaining Costco position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 533 Costco shares in Q1 2026, an estimated $460K.
PharVision Advisers first reported a position in Costco in Q2 2025 and held it in 3 quarters.
PharVision Advisers's Costco position peaked at $460K in Q4 2025.
4,238 funds tracked by Wall St. Rank held Costco as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.